Tandem Diabetes Care (TNDM) Leases (2019 - 2026)

Tandem Diabetes Care (TNDM) has 8 years of Leases data on file, last reported at $95.7 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 5.22% year-over-year to $95.7 million; the trailing twelve-month figure through Mar 2026 stood at $95.7 million (down 5.22% YoY), and the FY2025 full-year result was $96.2 million, up 12.74% from the prior year.
• Leases for Q1 2026 stood at $95.7 million, roughly flat from $96.2 million in the prior quarter.
• Across five years, Leases topped out at $126.7 million in Q2 2022 and bottomed at $85.3 million in Q4 2024.
• The 5-year median for Leases is $96.2 million (2025), against an average of $98.4 million.
• The widest annual swing landed in 2022, when Leases surged 611.92%; it then slipped 28.12% in 2023.
• A 5-year view of Leases shows it stood at $110.6 million in 2022, then dropped by 20.64% to $87.8 million in 2023, then fell by 2.83% to $85.3 million in 2024, then rose by 12.74% to $96.2 million in 2025, then fell by 0.45% to $95.7 million in 2026.
• The last three Leases figures came in at $95.7 million (Q1 2026), $96.2 million (Q4 2025), and $98.4 million (Q3 2025), per Business Quant data.

Peer Comparison